-Tamoxifen and the endometrium: monitoring and evaluation of endometrial changes-.
Rageth
J C
JC
Spital Limmattal, Gynäkologie und Geburtshilfe, Schlieren, Switzerland.
Bronz
L
L
Granberg
S
S
D016588:Anticarcinogenic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D001943:Breast Neoplasms / Q000517:prevention & control*; D003952:Diagnostic Imaging; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000473:pathology; D004717:Endometrium / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D012307:Risk Factors; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
D016588:Anticarcinogenic Agents; D013629:Tamoxifen